Nivolumab plus docetaxel in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: results from the phase II CheckMate 9KD trial

1. Fizazi, K.
2. González Mella, P.
3. Castellano, D.
4. Minatta, J.N.
5. Rezazadeh Kalebasty, A.
6. Shaffer, D.
7. Vázquez Limón, J.C.
8. Sánchez López, H.M.
9. Armstrong, A.J.
10. Horvath, L.
11. Bastos, D.A.
12. Amin, N.P.
13. Li, J.
14. Unsal-Kacmaz, K.
15. Retz, M.
16. Saad, F.
17. Petrylak, D.P.
18. Pachynski, R.K.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.EJCA.2021.09.043 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus